Sign in or Register   Sign in or Register
  |  

ACSL4

ACSL4 is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA
Full Name
Acyl-CoA Synthetase Long Chain Family Member 4
Function
Catalyzes the conversion of long-chain fatty acids to their active form acyl-CoA for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially activates arachidonate and eicosapentaenoate as substrates. Preferentially activates 8,9-EET> 14,15-EET> 5,6-EET> 11,12-EET. Modulates glucose-stimulated insulin secretion by regulating the levels of unesterified EETs (By similarity). Modulates prostaglandin E2 secretion.
Biological Process
Dendritic spine development
Embryonic process involved in female pregnancy
Fatty acid metabolic process
Fatty acid transport
Lipid biosynthetic process
Lipid metabolic process
Long-chain fatty acid metabolic process
Long-chain fatty-acyl-CoA biosynthetic process
Long-chain fatty-acyl-CoA metabolic process
Negative regulation of prostaglandin secretion
Neuron differentiation
Positive regulation of cell growth
Positive regulation of insulin secretion
Response to interleukin-15
Response to nutrient
Triglyceride biosynthetic process
Cellular Location
Cell membrane; Microsome membrane; Endoplasmic reticulum membrane; Peroxisome membrane; Mitochondrion outer membrane
Involvement in disease
Mental retardation, X-linked 63 (MRX63): A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations.
Alport syndrome with mental retardation, midface hypoplasia and elliptocytosis (ATS-MR): An X-linked contiguous gene deletion syndrome characterized by glomerulonephritis, sensorineural hearing loss, mental retardation, midface hypoplasia and elliptocytosis.
Topology
Helical: 8-28 aa
Cytoplasmic: 29-711 aa

Anti-ACSL4 antibodies

Loading...
Target: ACSL4
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: V2-160818
Application*: WB, P, IF
Target: ACSL4
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Mouse, Rat
Clone: V2-161661
Application*: P, WB
Target: ACSL4
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: V2-161662
Application*: WB
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
IFImmunofluorescence
IHImmunohistochemistry
IPImmunoprecipitation
WBWestern Blot
EELISA
MMicroarray
CIChromatin Immunoprecipitation
FFlow Cytometry
FNFunction Assay
IDImmunodiffusion
RRadioimmunoassay
TCTissue Culture
GSGel Supershift
NNeutralization
BBlocking
AActivation
IInhibition
DDepletion
ESELISpot
DBDot Blot
MCMass Cytometry/CyTOF
CTCytotoxicity
SStimulation
AGAgonist
APApoptosis
IMImmunomicroscopy
BABioassay
CSCostimulation
EMElectron Microscopy
IEImmunoelectrophoresis
PAPeptide Array
ICImmunocytochemistry
PEPeptide ELISA
MDMeDIP
SHIn situ hybridization
IAEnzyme Immunoassay
SEsandwich ELISA
PLProximity Ligation Assay
ECELISA(Cap)
EDELISA(Det)
BIBioimaging
IOImmunoassay
LFLateral Flow Immunoassay
LALuminex Assay
CImmunohistochemistry-Frozen Sections
PImmunohistologyp-Paraffin Sections
ISIntracellular Staining for Flow Cytometry
MSElectrophoretic Mobility Shift Assay
RIRNA Binding Protein Immunoprecipitation (RIP)
Go to
Compare